Filing Flows › Orthofix Medical (OFIX) › Q4 FY25
Orthofix Medical (OFIX) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Feb 24, 2026
Orthofix Medical (OFIX) reported revenue of $220M for the fourth quarter fiscal 2025 (Q4 FY25), +2% from a year earlier and +7% from the quarter before. Operating margin was 0.2%, net loss $2.2M (1.0% of revenue).
Orthofix Medical, Q4 FY25: revenue $220M (+2% year over year), operating margin 0.2%, net loss $2.2M, operating cash flow $27.7M. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $220M | +7% | +2% |
| Operating profit | $494K | — | — |
| Net earnings | −$2.2M | — | — |
| Operating cash flow | $27.7M | +123% | +17% |
| Free cash flow | $16.8M | +573% | +11% |
What changed
Revenue was $219.9M in Q4 FY25, up 2% year over year and up 7% from the previous quarter.
Gross margin was 71.1%, up 2.1 points from Q4 FY24. Operating profit was $494K, a 0.2% margin (up 5.5 points year over year). Operating expenses fell 3% while revenue rose 2%. The quarter ended with a net loss of $2.2M, narrower than the previous quarter's $22.8M loss. Net interest and other expense of $2.7M was the main reason.
Operating cash flow was $27.7M (up 17% year over year). Non-cash charges added back $13.1M of depreciation and amortization and $7.2M of share-based compensation. Working capital and other items added $9.6M. Capital expenditures of $10.9M left free cash flow of $16.8M.
Questions
What was Orthofix Medical's revenue in the fourth quarter fiscal 2025?
Orthofix Medical (OFIX) reported revenue of $220M for the fourth quarter fiscal 2025 (Q4 FY25), +2% from a year earlier and +7% from the quarter before.
Was Orthofix Medical profitable in the fourth quarter fiscal 2025?
Operating profit was $494K (0.2% of revenue) and net loss $2.2M.
Source: Orthofix Medical 10-K on SEC EDGAR.